MENU

NCNA Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom NCNA on March 26, 2025, netting in a 15.04% gain over 4 weeks

A.I.dvisor
at Tickeron.com
Loading...
+15.04% Gain from a Successful pattern Head-and-Shoulders Bottom
NCNA - NuCana plc
Tickeron
Ticker: NCNA
Company: NuCana plc
Gain: +15.04%
Confirmed: 03/26/25
Succeeded: 03/27/25
Total length: 30 days
On February 25, 2025, A.I.dvisor detected a Head-and-Shoulders Bottom Pattern (Bullish) for NuCana plc (NCNA, $0.93). On March 26, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.26. 1 day later, on March 27, 2025, NCNA reached the target price resulting in a +1 for traders who took a long position in the stock.

Momentum Indicator for NCNA turns positive, indicating new upward trend

NCNA saw its Momentum Indicator move above the 0 level on March 26, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 101 similar instances where the indicator turned positive. In of the 101 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NCNA just turned positive on March 19, 2025. Looking at past instances where NCNA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where NCNA advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NCNA moved out of overbought territory on March 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where NCNA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

NCNA moved below its 50-day moving average on March 31, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NCNA broke above its upper Bollinger Band on March 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NCNA entered a downward trend on March 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.709) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NCNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel anti-cancer medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
28
Web
https://www.nucana.com